[{"id":"romana-1-2","kind":"trial","name":"ROMANA 1 and ROMANA 2","route":"/trials/romana-1-2/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/nutrition.ts","type":"changed","fields":[{"field":"tldr","before":"\"Two phase 3 trials of an appetite-hormone mimic in lung cancer patients with wasting. Patients gained muscle but not grip strength, which split regulators: approved in Japan, rejected in Europe.\"","after":"\"ROMANA 1 and 2 were two phase 3 trials of an appetite-hormone mimic in lung cancer patients with wasting. Patients gained muscle but not grip strength, which split regulators: approved in Japan, rejected in Europe.\""}]},{"id":"romana-1-2","kind":"trial","name":"ROMANA 1 and ROMANA 2","route":"/trials/romana-1-2/","commit":"dd90cde211","date":"2026-09-08","author":"Jude Gomila","message":"Diet, exercise and lifestyle front content","file":"src/data/nutrition.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"nct"},{"field":"phase"},{"field":"status"},{"field":"yearReported"},{"field":"enrolled"},{"field":"sponsor"},{"field":"setting"},{"field":"tldr"},{"field":"summary"},{"field":"result"},{"field":"outcomes"},{"field":"replication"},{"field":"cancers"},{"field":"technologies"},{"field":"terms"},{"field":"pathways"},{"field":"institutions"},{"field":"sections"},{"field":"bottlenecks"},{"field":"related"},{"field":"links"}]}]